Background: Labor induction means stimulation of the uterine contractions for the production of deliveries before the start of spontaneous labour.
Aim of the Study: This study compared the efficacy and safety of vaginal misoprostol against intravenous oxytocin for inducing labour in pregnant women. with term prelabour membrane rupture.
Patients and Methods: From July 2021 to February 2022, patients at Al-Hussein University Hospital's Obstetrics and Gynecology Department participated in a randomised controlled trial.
Results: Uterine tachysystole was identified in 7.27 percent of the 55 women who took misoprostol.and (1.81%) had hypersysytole versus (10.90%) had tachysystole and (1.81%) had hyper systole in oxytocin group. There was no statistically significant difference in uterine issues between the misoprostol and oxytocin groups. Conclusion: Uses of vaginal misoprostol may be an alternative to intravenous oxytocin infusion for induction of labor, with efficacy and safety profile. Vaginal misoprostol was cheap, stable in room temperature, 24 hours, easy to administrate by many women.